{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:06:07Z","timestamp":1743152767076,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":78,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811377082"},{"type":"electronic","value":"9789811377099"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7709-9_2","type":"book-chapter","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:57:22Z","timestamp":1567537042000},"page":"25-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Production of Therapeutic Enzymes by Lentivirus Transgenesis"],"prefix":"10.1007","author":[{"given":"Mar\u00eda Celeste","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ceaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n","family":"Antu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Tardivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Etcheverrigaray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"issue":"2","key":"2_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.febslet.2013.11.035","volume":"588","author":"AD Bandaranayake","year":"2014","unstructured":"Bandaranayake AD, Almo SC (2014) Recent advances in mammalian protein production. FEBS Lett 588(2):253\u2013260","journal-title":"FEBS Lett"},{"key":"2_CR2","first-page":"379","volume":"64","author":"L Baranyi","year":"2010","unstructured":"Baranyi L, Roy A, Embree HD, Dropulic B (2010) Lentiviral vector-mediated genetic modification of cell substrates for the manufacture of proteins and other biologics. PDA J Pharm Sci Technol 64:379\u2013385","journal-title":"PDA J Pharm Sci Technol"},{"key":"2_CR500","doi-asserted-by":"crossref","unstructured":"Bennett LL, Mohan D (2013) Gaucher disease and its treatment options. Ann Pharmacother 47(9):1182\u201393","DOI":"10.1177\/1060028013500469"},{"key":"2_CR3","first-page":"605","volume":"1793","author":"T Braulke","year":"2009","unstructured":"Braulke T, Bonifacino JS (2009) Sorting of lysosomal proteins. BBA\u00a0\u2013 Mol Cell Res 1793:605\u2013614","journal-title":"BBA\u00a0\u2013 Mol Cell Res"},{"issue":"2","key":"2_CR4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10545-012-9481-2","volume":"36","author":"E Braunlin","year":"2013","unstructured":"Braunlin E, Rosenfeld H, Kampmann C et al (2013) Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme\u00ae) therapy. J Inherit Metab Dis 36(2):385\u2013394","journal-title":"J Inherit Metab Dis"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.copbio.2014.06.010","volume":"30","author":"M Butler","year":"2014","unstructured":"Butler M, Spearman M (2014) The choice of mammalian cell host and possibilities for glycosylation engineering. Curr Opin Biotechnol 30:107\u2013112","journal-title":"Curr Opin Biotechnol"},{"issue":"7\u20138","key":"2_CR6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.drudis.2007.02.010","volume":"12","author":"B Byrne","year":"2007","unstructured":"Byrne B, Donohoe GG, O\u2019Kennedy R (2007) Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today 12(7\u20138):319\u2013326","journal-title":"Drug Discov Today"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/adhm.201500746","volume":"5","author":"I Cabrera","year":"2016","unstructured":"Cabrera I, Abasolo I, Corchero JL et al (2016) \u03b1 -galactosidase-A-loaded Nanoliposomes with enhanced enzymatic activity and intracellular penetration. Adv Healthc Mater 5:829\u2013840","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"2_CR8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jbiosc.2017.06.005","volume":"124","author":"LA Cappellino","year":"2017","unstructured":"Cappellino LA, Kratje RB, Etcheverrigaray M et al (2017) Strategy for erythroid differentiation in ex vivo cultures: lentiviral genetic modification of human hematopoietic stem cells with erythropoietin gene. J Biosci Bioeng 124(5):591\u2013598","journal-title":"J Biosci Bioeng"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02254991","volume":"9","author":"MS Cho","year":"2002","unstructured":"Cho MS, Yee H, Chan S (2002) Establishment of a human somatic hybrid cell line for recombinant protein production. J Biomed Sci 9:631\u2013638","journal-title":"J Biomed Sci"},{"issue":"4","key":"2_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-014-9523-0","volume":"31","author":"YK Chung","year":"2014","unstructured":"Chung YK, Sohn YB, Sohn JM et al (2014) A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome. Glycoconj J 31(4):309\u2013315","journal-title":"Glycoconj J"},{"key":"2_CR11","doi-asserted-by":"crossref","unstructured":"Clark DP, Pazdernik NJ (2016) Chapter 10- recombinant proteins. In: Clark DP, Pazdernik NJ (ed) Biotechnology, 2nd edn. Academic Cell, p 355\u2013363","DOI":"10.1016\/B978-0-12-385015-7.00010-7"},{"issue":"5","key":"2_CR12","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/btpr.637","volume":"27","author":"JL Corchero","year":"2011","unstructured":"Corchero JL, Mendoza R, Lorenzo J et\u00a0al (2011) Integrated approach to produce a recombinant, his-tagged human \u03b1-galactosidase A in mammalian cells. Biotechnol Prog 27(5):1206\u20131217","journal-title":"Biotechnol Prog"},{"issue":"3","key":"2_CR13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/mt.2010.278","volume":"19","author":"K Cornetta","year":"2011","unstructured":"Cornetta K, Yao J, Jasti A et al (2011) Replication-competent lentivirus analysis of clinical grade vector products. Mol Ther 19(3):557\u2013566","journal-title":"Mol Ther"},{"issue":"12","key":"2_CR14","first-page":"1","volume":"25","author":"K Cornetta","year":"2017","unstructured":"Cornetta K, Duffy L, Turtle CJ et al (2017) Absence of replication-competent lentivirus in the clinic: analysis of infused T cell products. Mol Ther 25(12):1\u20139","journal-title":"Mol Ther"},{"issue":"10","key":"2_CR15","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.vaccine.2012.01.016","volume":"30","author":"MMJ Cox","year":"2012","unstructured":"Cox MMJ (2012) Recombinant protein vaccines produced in insect cells. Vaccine 30(10):1759\u20131766","journal-title":"Vaccine"},{"issue":"7","key":"2_CR16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/14712598.4.7.1167","volume":"4","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ (2004) Enzyme replacement therapy for Fabry disease: lessons from two alpha-galactosidase A orphan products and one FDA approval. Expert Opin Biol Ther 4(7):1167\u20131176","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"2_CR17","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00253-016-7973-y","volume":"101","author":"K Ding","year":"2017","unstructured":"Ding K, Han L, Zong H et al (2017) Production process reproducibility and product quality consistency of transient gene expression in HEK293 cells with anti-PD1 antibody as the model protein. Appl Microbiol Biotechnol 101(5):1889\u20131898","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"2_CR18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","volume":"36","author":"J Dumont","year":"2016","unstructured":"Dumont J, Euwart D, Mei B et al (2016) Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit Rev Biotechnol 36(6):1110\u20131122","journal-title":"Crit Rev Biotechnol"},{"issue":"8","key":"2_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0012194","volume":"5","author":"M Dvorak-Ewell","year":"2010","unstructured":"Dvorak-Ewell M, Wendt D, Hague C et al (2010) Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice. PLoS One 5(8):1\u201311","journal-title":"PLoS One"},{"issue":"2","key":"2_CR20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1525-0016(03)00167-9","volume":"8","author":"P Escarpe","year":"2003","unstructured":"Escarpe P, Zayek N, Chin P et al (2003) Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol Ther 8(2):332\u2013341","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"2_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2015.06.001","volume":"116","author":"\u00c1J Espejo-Mojica","year":"2015","unstructured":"Espejo-Mojica \u00c1J, Alm\u00e9ciga-D\u00edaz CJ, Rodr\u00edguez A et al (2015) Human recombinant lysosomal enzymes produced in microorganisms. Mol Genet Metab 116(1\u20132):13\u201323","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2_CR22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40256-016-0203-2","volume":"16","author":"JE Frampton","year":"2016","unstructured":"Frampton JE (2016) Sebelipase alfa: a review in lysosomal acid lipase deficiency. Am J Cardiovasc Drugs 16(6):461\u2013468","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"2_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bit.22698","volume":"106","author":"B Gaillet","year":"2010","unstructured":"Gaillet B, Gilbert R, Broussau S et al (2010) High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch. Biotechnol Bioeng 106(2):203\u2013215","journal-title":"Biotechnol Bioeng"},{"issue":"7","key":"2_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 31(7):397\u2013405","journal-title":"Trends Biotechnol"},{"issue":"5","key":"2_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/07388551.2016.1214557","volume":"37","author":"SK Gupta","year":"2017","unstructured":"Gupta SK, Shukla P (2017) Gene editing for cell engineering: trends and applications. Crit Rev Biotechnol 37(5):672\u2013684","journal-title":"Crit Rev Biotechnol"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.sbi.2016.06.005","volume":"38","author":"DL Hacker","year":"2016","unstructured":"Hacker DL, Balasubramanian S (2016) Recombinant protein production from stable mammalian cell lines and pools. Curr Opin Struct Biol 38:129\u2013136","journal-title":"Curr Opin Struct Biol"},{"issue":"7","key":"2_CR27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/biot.201400649","volume":"10","author":"N Harraghy","year":"2015","unstructured":"Harraghy N, Calabrese D, Fisch I et al (2015) Epigenetic regulatory elements: recent advances in understanding their mode of action and use for recombinant protein production in mammalian cells. Biotechnol J 10(7):967\u2013978","journal-title":"Biotechnol J"},{"issue":"2","key":"2_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10719-009-9261-x","volume":"27","author":"E Higgins","year":"2010","unstructured":"Higgins E (2010) Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J 27(2):211\u2013225","journal-title":"Glycoconj J"},{"key":"2_CR501","doi-asserted-by":"crossref","unstructured":"Ioannou YA, Bishop DF, Desnick RJ (1992) Overexpression of human a-galactosidase a results in its intracellular aggregation, crystallization in lysosomes, and selective secretion. J Cell Biol 119:1137\u201350","DOI":"10.1083\/jcb.119.5.1137"},{"issue":"4","key":"2_CR29","first-page":"CD009354","volume":"9","author":"E Jameson","year":"2013","unstructured":"Jameson E, Jones S, Remmington T (2013) Enzyme replacement therapywith laronidase (Aldurazyme\u00ae) for treating mucopolysaccharidosis type I. Cochrane Database Syst Rev 9(4):CD009354","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2_CR30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/gt.2012.76","volume":"20","author":"JM Johnston","year":"2012","unstructured":"Johnston JM, Denning G, Doering CB et al (2012) Generation of an optimized lentiviral vector encoding a high- expression factor VIII transgene for gene therapy of hemophilia A. Gene Ther 20(6):607\u201361576","journal-title":"Gene Ther"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2016.02.004","volume":"501","author":"J-Y Kang","year":"2016","unstructured":"Kang J-Y, Kwon O, Gil JY et al (2016) Comparison of fluorescent tags for analysis of mannose-6-phosphate glycans. Anal Biochem 501:1\u20133","journal-title":"Anal Biochem"},{"issue":"2","key":"2_CR33","first-page":"257","volume":"3","author":"KH Khan","year":"2013","unstructured":"Khan KH (2013) Gene expression in mammalian cells and its applications. Adv Pharm Bull 3(2):257\u2013263","journal-title":"Adv Pharm Bull"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymgme.2014.08.002","volume":"114","author":"T Kizhner","year":"2015","unstructured":"Kizhner T, Azulay Y, Hainrichson M et al (2015) Characterization of a chemically modified plant cell culture expressed human \u03b1-galactosidase-A enzyme for treatment of Fabry disease. Mol Genet Metab 114:259\u2013267","journal-title":"Mol Genet Metab"},{"key":"2_CR31","doi-asserted-by":"crossref","unstructured":"Kumar Kakkar A, Dahiya N (2014) From Blockbusters to Niche Busters. Drug Dev Res 75:231\u2013234","DOI":"10.1002\/ddr.21176"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-981-10-4284-3_2","volume":"2","author":"S Kumar","year":"2017","unstructured":"Kumar S, Abdulhameed S (2017) Therapeutic enzymes. Bioresour Bioprocess Biotechnol 2:45\u201373","journal-title":"Bioresour Bioprocess Biotechnol"},{"issue":"113","key":"2_CR36","first-page":"1","volume":"6","author":"HAD Lagass\u00e9","year":"2017","unstructured":"Lagass\u00e9 HAD, Alexaki A, Simhadri VL et al (2017) Recent advances in (therapeutic protein) drug development [version 1; referees: 2 approved]. F1000Res. 2017 6(113):1\u20137","journal-title":"F1000Res"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jbiotec.2017.04.028","volume":"251","author":"ME Lalonde","year":"2017","unstructured":"Lalonde ME, Durocher Y (2017) Therapeutic glycoprotein production in mammalian cells. J Biotechnol 251:128\u2013140","journal-title":"J Biotechnol"},{"issue":"4","key":"2_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwg034","volume":"13","author":"K Lee","year":"2003","unstructured":"Lee K, Jin X, Zhang K et al (2003) A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease. Glycobiology 13(4):305\u2013313","journal-title":"Glycobiology"},{"issue":"4","key":"2_CR39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00003088-200544040-00001","volume":"44","author":"I Mahmood","year":"2005","unstructured":"Mahmood I, Green MD (2005) Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins. Clin Pharmacokinet 44(4):331\u2013347","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"2_CR40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7150\/ijms.11270","volume":"12","author":"Y Mao","year":"2015","unstructured":"Mao Y, Yan R, Li A et al (2015) Lentiviral vectors mediate long-term and high efficiency transgene expression in HEK 293T cells. Int J Med Sci 12(5):407\u2013415","journal-title":"Int J Med Sci"},{"issue":"6","key":"2_CR41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.celrep.2015.04.007","volume":"11","author":"FT Merkle","year":"2015","unstructured":"Merkle FT, Neuhausser WM, Santos D et al (2015) Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep 11(6):875\u2013883","journal-title":"Cell Rep"},{"key":"2_CR42","doi-asserted-by":"crossref","unstructured":"Merten O-W, Hebben M, Bovolenta C (2016) Production of lentiviral vectors. Mol Ther Methods Clin Dev 3:1\u201314","DOI":"10.1038\/mtm.2016.17"},{"key":"2_CR43","first-page":"e1380","volume":"9","author":"AM Moreno","year":"2017","unstructured":"Moreno AM, Mali P (2017) Therapeutic genome engineering via CRISPR-Cas systems. Syst Biol Med 9:e1380","journal-title":"Syst Biol Med"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pep.2013.11.005","volume":"95","author":"EF Mufarrege","year":"2014","unstructured":"Mufarrege EF, Antu\u00f1a S, Etcheverrigaray M et al (2014) Development of lentiviral vectors for transient and stable protein overexpression in mammalian cells. A new strategy for recombinant human FVIII (rhFVIII) production. Protein Expr Purif 95:50\u201356","journal-title":"Protein Expr Purif"},{"issue":"3","key":"2_CR45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/bit.22968","volume":"108","author":"A Oberbek","year":"2011","unstructured":"Oberbek A, Matasci M, Hacker DL (2011) Generation of stable, high-producing cho cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture. Biotechnol Bioeng 108(3):600\u2013610","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"2_CR46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5483\/BMBRep.2015.48.8.101","volume":"48","author":"DB Oh","year":"2015","unstructured":"Oh DB (2015) Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases. BMB Rep 48(8):438\u2013444","journal-title":"BMB Rep"},{"issue":"1","key":"2_CR47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","volume":"66","author":"G Parenti","year":"2015","unstructured":"Parenti G, Andria G, Ballabio A (2015) Lysosomal storage diseases: from pathophysiology to therapy. Annu Rev Med 66(1):471\u2013486","journal-title":"Annu Rev Med"},{"issue":"2","key":"2_CR48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/187221512801327433","volume":"6","author":"V Pican\u00e7o-Castro","year":"2012","unstructured":"Pican\u00e7o-Castro V, de Sousa Russo-Carbolante EM, Tadeu Covas D (2012) Advances in lentiviral vectors: a patent review. Recent Pat DNA Gene Seq 6(2):82\u201390","journal-title":"Recent Pat DNA Gene Seq"},{"key":"2_CR49","first-page":"386","volume":"64","author":"C Plewa","year":"2010","unstructured":"Plewa C (2010) Application of lentiviral vectors for development of production cell lines and safety testing of lentiviral-derived cells or products PDA. J Pharm Sci Technol 64:386\u2013391","journal-title":"J Pharm Sci Technol"},{"issue":"3","key":"2_CR50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cbic.201500280","volume":"17","author":"JL Porter","year":"2016","unstructured":"Porter JL, Rusli RA, Ollis DL (2016) Directed evolution of enzymes for industrial biocatalysis. Chembiochem 17(3):197\u2013203","journal-title":"Chembiochem"},{"issue":"Suppl 8","key":"2_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1753-6561-5-S8-P7","volume":"5","author":"C Prieto","year":"2011","unstructured":"Prieto C, Fontana D, Etcheverrigaray M et al (2011) A strategy to obtain recombinant cell lines with high expression levels. Lentiviral vector-mediated transgenesis. BMC Proc 5(Suppl 8):7\u20138","journal-title":"BMC Proc"},{"issue":"5","key":"2_CR52","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/btpr.2538","volume":"33","author":"MC Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez MC, Ceaglio N, Antu\u00f1a S et al (2017) High yield process for the production of active human a -galactosidase a in CHO-K1 cells through lentivirus transgenesis. Biotechnol Prog 33(5):1334\u20131345","journal-title":"Biotechnol Prog"},{"issue":"8","key":"2_CR53","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/bit.25233","volume":"111","author":"C Ronda","year":"2014","unstructured":"Ronda C, Pedersen LE, Hansen HG et al (2014) Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool. Biotechnol Bioeng 111(8):1604\u20131616","journal-title":"Biotechnol Bioeng"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/BJ20120146","volume":"443","author":"T Sakuma","year":"2012","unstructured":"Sakuma T, Barry MA, Ikeda Y (2012) Lentiviral vectors: basic to translational. Biochem J 443:603\u2013618","journal-title":"Biochem J"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10038-005-0342-9","volume":"51","author":"H Sakuraba","year":"2006","unstructured":"Sakuraba H, Murata-Ohsawa M, Kawashima I et al (2006) Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice. J Hum Genet 51:180\u2013188","journal-title":"J Hum Genet"},{"issue":"5","key":"2_CR56","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ymthe.2003.08.003","volume":"8","author":"L Sastry","year":"2003","unstructured":"Sastry L, Xu Y, Johnson T et al (2003) Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol Ther 8(5):830\u2013839","journal-title":"Mol Ther"},{"key":"2_CR57","unstructured":"Selden RF, Borowski M, Kinoshita CM et al (2000) Medical preparations for the treatment of alpha-galactosidase a deficiency. WO 00\/53730 A3 14 Sept 2000"},{"key":"2_CR58","first-page":"79","volume":"5","author":"S Sestito","year":"2015","unstructured":"Sestito S, Grisolia M, Concolino D (2015) Profile of idursulfase for the treatment of Hunter syndrome. Res Reports Endocr Disord 5:79\u201390","journal-title":"Res Reports Endocr Disord"},{"issue":"4","key":"2_CR59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jth.13632","volume":"15","author":"SA Shestopal","year":"2017","unstructured":"Shestopal SA, Hao J-J, Karnaukhova E et al (2017) Expression and characterization of a codon-optimized blood coagulation factor VIII. J Thromb Haemost 15(4):709\u2013720","journal-title":"J Thromb Haemost"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2017.09.001","volume":"8","author":"LM Skrdlant","year":"2017","unstructured":"Skrdlant LM, Armstrong RJ, Keidaisch BM et al (2017) Detection of replication competent lentivirus using a qPCR assay for VSV-G. Mol Ther Methods Clin Dev 8:1\u20137","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"2_CR61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1172-8-2","volume":"8","author":"YB Sohn","year":"2013","unstructured":"Sohn YB, Cho SY, Park SW et al (2013a) Phase I\/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome). Orphanet J Rare Dis 8(1):2\u20139","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2_CR62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5483\/BMBRep.2013.46.3.192","volume":"46","author":"Y Sohn","year":"2013","unstructured":"Sohn Y, Lee JM, Park H et al (2013b) Enhanced sialylation and in vivo efficacy of recombinant human \u03b1-galactosidase through in vitro glycosylation. BMB Rep 46(3):157\u2013162","journal-title":"BMB Rep"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2017.05.004","volume":"118","author":"M Solomon","year":"2017","unstructured":"Solomon M, Muro S (2017) Lysosomal enzyme replacement therapies: historical development, clinical outcomes, and future perspectives Melani. Adv Drug Deliv Rev 118:109\u2013134","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"2_CR64","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/mt.2010.239","volume":"19","author":"HT Spencer","year":"2011","unstructured":"Spencer HT, Denning G, Gautney RE et al (2011) Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII. Mol Ther 19(2):302\u2013309","journal-title":"Mol Ther"},{"issue":"1","key":"2_CR65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbiotec.2014.12.009","volume":"195","author":"S Spencer","year":"2015","unstructured":"Spencer S, Gugliotta A, Koenitzer J et\u00a0al (2015) Stability of single copy transgene expression in CHOK1 cells is affected by histone modifications but not by DNA methylation. J Biotechnol 195(1):15\u201329","journal-title":"J Biotechnol"},{"issue":"1","key":"2_CR66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pep.2012.04.023","volume":"84","author":"K Swiech","year":"2012","unstructured":"Swiech K, Pican\u00e7o-Castro V, Covas DT (2012) Human cells: new platform for recombinant therapeutic protein production. Protein Expr Purif 84(1):147\u2013153","journal-title":"Protein Expr Purif"},{"issue":"11","key":"2_CR67","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","volume":"3","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Sawamoto K, Shimada T et al (2015) Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs 3(11):1279\u20131290","journal-title":"Expert Opin Orphan Drugs"},{"issue":"1","key":"2_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.11.016","volume":"515","author":"S Turan","year":"2013","unstructured":"Turan S, Zehe C, Kuehle J et\u00a0al (2013) Recombinase-mediated cassette exchange (RMCE)\u00a0\u2013 a rapidly-expanding toolbox for targeted genomic modifications. Gene 515(1):1\u201327","journal-title":"Gene"},{"issue":"4","key":"2_CR69","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.tiv.2010.03.016","volume":"24","author":"J Van der Valk","year":"2010","unstructured":"Van der Valk J, Brunner D, De Smet K et al (2010) Optimization of chemically defined cell culture media\u00a0\u2013 replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24(4):1053\u20131063","journal-title":"Toxicol In Vitro"},{"issue":"8","key":"2_CR70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","volume":"14","author":"A Varki","year":"2008","unstructured":"Varki A (2008) Sialic acids in human health and disease. Trends Mol Med 14(8):351\u2013360","journal-title":"Trends Mol Med"},{"issue":"8","key":"2_CR71","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamapediatrics.2015.0754","volume":"169","author":"HJ Vernon","year":"2015","unstructured":"Vernon HJ (2015) Inborn errors of metabolism: advances in diagnosis and therapy. JAMA Pediatr 169(8):778\u2013782","journal-title":"JAMA Pediatr"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.copbio.2007.07.013","volume":"18","author":"D Wirth","year":"2007","unstructured":"Wirth D, Gama-Norton L, Riemer P et al (2007) Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 18:411\u2013419","journal-title":"Curr Opin Biotechnol"},{"issue":"11","key":"2_CR73","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nbt1026","volume":"22","author":"FM Wurm","year":"2004","unstructured":"Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22(11):1393\u20131398","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2_CR74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/pr1030296","volume":"1","author":"FM Wurm","year":"2013","unstructured":"Wurm FM (2013) CHO Quasispecies\u00a0\u2013 implications for manufacturing processes. Processes 1(3):296\u2013311","journal-title":"Processes"},{"issue":"1","key":"2_CR75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.13052","volume":"1371","author":"M Xu","year":"2016","unstructured":"Xu M, Motabar O, Ferrer M et al (2016) Disease models for the development of therapies for lysosomal storage diseases. Ann N Y Acad Sci 1371(1):15\u201329","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2_CR76","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1248\/bpb.b13-00661","volume":"37","author":"F Zhang","year":"2014","unstructured":"Zhang F, Liu M, Wan H (2014) Discussion about several potential drawbacks of PEGylated therapeutic proteins. Biol Pharm Bull 37(3):335\u2013339","journal-title":"Biol Pharm Bull"}],"container-title":["Advances in Experimental Medicine and Biology","Therapeutic Enzymes: Function and Clinical Implications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7709-9_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:34:27Z","timestamp":1721687667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-13-7709-9_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811377082","9789811377099"],"references-count":78,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7709-9_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"4 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}